Visco VisionTPE:6782 +2.31%92 Days Payable is 32.93 as of Dec. 2025, which is 1% above its 10-year median of 32.58. GuruFocus rates TPE:6782 with a GF Score™ of 92/100 and a GF Value™ of NT$324.78 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, Visco Vision ranks worse than 82.14% on this metric.
The historical rank and industry rank for Visco Vision's Days Payable or its related term are showing as below:
TPE:6782'
s Days Payable Range Over the Past 10 Years
Min: 8.67 Med: 32.58 Max: 50.92
Current: 32.81
During the past 9 years, Visco Vision's highest Days Payable was 50.92. The lowest was 8.67. And the median was 32.58.
TPE:6782's Days Payable is ranked worse than 82.14% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs TPE:6782: 32.81
Visco Vision's Days Payable
declined
from Dec. 2024 (33.71) to Dec. 2025 (32.93).
It may suggest that Visco Visionaccelerated paying its suppliers.
Visco Vision Days Payable Related Terms
Visco Vision Days Payable Historical Data
* Premium members only.
The historical data trend for Visco Vision's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6782 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Visco Vision's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's Days Payable distribution charts can be found below:
* The bar in red indicates where Visco Vision's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Visco Vision's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Visco Vision (TPE:6782) has a Days Payable of 32.93 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Visco Vision and its competitors. This is near median its historical median of 32.58. Over the past decade, Visco Vision's Days Payable has ranged from 8.67 to 50.92. According to the industry distribution chart, Visco Vision ranks #653 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 82.1%.
Is Visco Vision's Days Payable too high?
Visco Vision's current Days Payable of 32.93 is near median its 10-year median of 32.58. Over the past 10 years, this metric has ranged from a low of 8.67 to a high of 50.92. The Medical Devices & Instruments industry median Days Payable is 68.07. Visco Vision's value of 32.93 is 51.6% below this industry median. Based on the distribution chart, Visco Vision ranks #653 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Visco Vision has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #653 out of 795 companies for Days Payable. This places Visco Vision in the lower half of its industry. The industry median Days Payable is 68.07. Visco Vision's value of 32.93 is 51.6% below this benchmark. Historically, Visco Vision's own Days Payable has ranged from 8.67 to 50.92 over the past decade. While the company's 10-year median is 32.58 vs. the industry median of 68.07, Visco Vision has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visco Vision's current Days Payable of 32.93 is 51.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current Days Payable is 32.93, which is near median its own 10-year median of 32.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$324.78, compared to a current price of NT$199.50 — trading 38.6% below its estimated fair value. The current Days Payable is 32.93, which is near median its 10-year median of 32.58 and 51.6% below the Medical Devices & Instruments industry median of 68.07. Visco Vision's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current Days Payable is 32.93 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$199.50 is trading 38.6% below its estimated GF Value™ of NT$324.78.
GuruFocus considers Visco Vision to be Significantly Undervalued.
Key valuation signals for TPE:6782:
Days Payable: 32.93 (near median its 10-year median of 32.58)
GF Value™: NT$324.78 vs. price of NT$199.50 (38.6% below fair value)
Industry Position: 51.6% below the Medical Devices & Instruments median (#653 of 795)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
92GF Score
Get the complete analysis for TPE:6782
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
